EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma

Seung Kak Shin iD, Sooyeon Oh, Su-Kyung Chun, Min-Ji Ahn, Seung-Min Lee, Kayun Kim, Hogyeong Kang, Jeongwoo Lee, Suk Pyo Shin, Jooho Lee, Young Kul Jung iD

Journal of Gastroenterology and Hepatology · 2024-09 · 39 (9) · 1717-1727

DOI: 10.1111/jgh.16584 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 27.05.2024. Verfasst von Seung Kak Shin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal medicine, Gachon University Gil Medical Center, College of Medicine, Gachon Unive…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Ministry of Health and Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells are one of the key members of innate immunity that predominantly reside in the liver, potentiating immune responses against viral infections or malignant tumors. It has been reported that changes in cell numbers and function of NK cells are associated with the development and progression of chronic liver diseases (CLDs) including non‐alcoholic fatty liver disease, alcoholic liver disease, and chronic viral hepatitis. Also, it is known that the crosstalk between NK cells and hepatic stellate cells plays an important role in liver fibrosis and cirrhosis. In particular, the impaired functions of NK cells observed in CLDs consequently contribute to occurrence and progression of hepatocellular carcinoma (HCC). Chronic infections by hepatitis B or C viruses counteract the anti‐tumor immunity of the host by producing the sheddases. Soluble major histocompatibility complex class I polypeptide‐related sequence A (sMICA), released from the cell surfaces by sheddases, disrupts the interaction and affects the function of NK cells. Recently, the MICA/B‐NK stimulatory receptor NK group 2 member D (NKG2D) axis has been extensively studied in HCC. HCC patients with low membrane‐bound MICA or high sMICA concentration have been associated with poor prognosis. Therefore, reversing the sMICA‐mediated downregulation of NKG2D has been proposed as an attractive strategy to enhance both innate and adaptive immune responses against HCC. This review aims to summarize recent studies on NK cell immune signatures and its roles in CLD and hepatocellular carcinogenesis and discusses the therapeutic approaches of MICA/B‐NKG2D‐based or NK cell‐based immunotherapy for HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalLiver NeoplasmsCarcinoma, HepatocellularHumansHistocompatibility Antigens Class INK Cell Lectin-Like Receptor Subfamily KChronic DiseaseLiver DiseasesImmunity, InnateNon-alcoholic Fatty Liver DiseaseDisease Progression

Stichwörter der Autor:innen

Chronic liver diseaseHepatic stellate cellsHepatocellular carcinomaLiver fibrosisNatural killer cells

Substanzen

Histocompatibility Antigens Class IMHC class I-related chain ANK Cell Lectin-Like Receptor Subfamily KKLRK1 protein, human

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal medicine, Gachon University Gil Medical Center, College of Medicine, Gachon University, Incheon, South Korea.
  • Chaum Life Center, School of Medicine, CHA University, Seoul, South Korea.
  • Center for Research and Development, CHA Advanced Research Institute, Seoul, South Korea.
  • School of Medicine, CHA University, Seoul, South Korea.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, South Korea.
  • Department of Internal Medicine, Korea University Ansan Hospital, Ansan, South Korea.

ORCID-Profile: Seung Kak Shin, Young Kul Jung

Förderung

  • Ministry of Health and Welfare, Republic of Korea

Zitieren

APA

Shin, S. K., Oh, S., Chun, S. K., Ahn, M. J., Lee, S. M., Kim, K., Kang, H., Lee, J., Shin, S. P., Lee, J., & Jung, Y. K. (2024). Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma. Journal of Gastroenterology and Hepatology, 39(9), 1717-1727. https://doi.org/10.1111/jgh.16584

Vancouver

Shin SK, Oh S, Chun SK, Ahn MJ, Lee SM, Kim K, et al. Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 2024;39(9):1717-1727. doi:10.1111/jgh.16584

BibTeX
@article{Shin2024,
  author = {Shin, Seung Kak and Oh, Sooyeon and Chun, Su-Kyung and Ahn, Min-Ji and Lee, Seung-Min and Kim, Kayun and Kang, Hogyeong and Lee, Jeongwoo and Shin, Suk Pyo and Lee, Jooho and Jung, Young Kul},
  title = {Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  volume = {39},
  number = {9},
  pages = {1717--1727},
  doi = {10.1111/jgh.16584}
}
Kostenlos starten →